Aurobindo Pharma Recovers 5% After Company's Clarification on US Health Regulator's Observations

In a regulatory filing post market hours on Monday, Aurobindo Pharma said that it is 'confident of addressing these issues within the stipulated timeline'.
Market Update
SENSEX 31,622.48 -187.07(%)
NIFTY 9,898.00 -54.2(%)

Top News